Appetite for Answers: Understanding GLP-1s Beyond the Headlines
$25.00
On Demand
Webinar for professionals presented by Ragen Chastain, MEd, BCPA
GLP-1 medications are currently a major topic of discussion, and unfortunately, misinformation is spreading—not only among the general public but also within the healthcare field. In this first installment of a three-part series, we’ll explore this new generation of drugs, their approved uses, and the research behind their FDA approval for weight loss, including study methods, findings, and potential conflicts of interest. We’ll also examine how these medications affect eating behavior, such as appetite suppression, side effects, and shifts in one’s relationship with food. Finally, we’ll address the potential harms of these drugs in reinforcing weight stigma and promoting a view of body size as a medical problem.
Pending approval for 1 Level II CEUs from the Commission on Dietetic Registration.
Your purchase will give you access to the recording for three years.
Student and equity discounts available. Please contact [email protected] for more information.
Learning Objectives
Upon completion of this webinar, participants will be able to:
-
Explain the development and original intended use of GLP-1 agonists.
-
Discuss key findings from early research on GLP-1 drugs, including effects on weight loss, health outcomes, and side effects.
-
Critically evaluate media and healthcare messaging related to GLP-1 agonists for accuracy and bias.
Additional information
Weight | 13 lbs |
---|---|
Dimensions | 10 × 11 × 12 in |
Reviews
There are no reviews yet.